Scientific Sessions

Explore the Breadth of Lab Medicine

Scientific Sessions represent the core of ADLM 2024 with nearly 70 sessions taking place from Monday – Thursday. Scientific Sessions brings the latest scientific advances and practical tools on all aspects of laboratory medicine. They include a wide variety of formats from case-based discussion, point-counterpoint, mock courtroom, and more. Scientific Sessions also include specially developed and invited sessions from ADLM collaborations and divisions.

Register Now
Online Session Search

Browse by day to explore the details of the full scientific program to make the most of your ADLM 2024 experience.


Browse by Day

Monday, July 29

Tuesday, July 30

Wednesday, July 31

Thursday, August 1


Monday, July 29

10:30 a.m. – 12 p.m.

ADLM President Invited Session
32101 Community Engagement, Research, and Healthcare: Laboratory Medicine’s Lead Role in Ensuring Health Equity

Moderator: Octavia Peck Palmer, PhD, FADLM, University of Pittsburgh Medical Center
Speakers:

  • Addressing Health Equity Throughout the Total Laboratory Testing Process
    Vahid Azimi, MD, Washington University
  • Point-of-Care Diagnostics Provide Equitable Access to Healthcare
    Omai Garner, PhD, ABMM, MT (ASCP), University of California, Los Angeles
  • Interdisciplinary Approaches to Eliminate Maternal Health Inequities
    Esa Davis, MD, MPH. FAAFP, University of Maryland School of Medicine

32102 Bad, Better, Best: Putting Data Visualizations to the Test
Moderator: T. Scott Isbell, PhD, DABCC, FADLM, Saint Louis University School of Medicine
Speakers:

  • A Journey in Data Visualization: You be the Judge!
    T. Scott Isbell, PhD, DABCC, FADLM, Saint Louis University School of Medicine
  • Case Presentations: Data Visualizations for Presentations and Reports
    Shannon Haymond, PhD, DABCC, FAACC, Lurie Children's
  • Case Presentations: Enhancing the Accessibility of Data Visualizations
    Christopher McCudden, PhD, DABCC, FACB, FCAC, The Ottawa Hospital General Campus

32103 Real-Time Mass Spectrometry: Strategies for Rapid Drug and Metabolite Detection to Enhance Clinical Decision Making
Moderator: Dennis Dietzen, PhD, DABCC, FADLM, Washington University School of Medicine
Speakers:

  • Past, Present, and Future Clinical Mass Spectrometry Applications
    Stephen Roper, PhD, DABCC, NRCC, Washington University School of Medicine
  • Design and Implementation of Direct to Mass Spectrometry Drug Screening in Children
    Stephen Roper, PhD, DABCC, NRCC, Washington University School of Medicine
  • Internal vs. External Calibration for Determination of Plasma Methotrexate by LC-MS/MS
    Dennis Dietzen, PhD, DABCC, FADLM, Washington University School of Medicine
  • Rapid Metabolic Detection of Mutant Isocitrate Dehydrogenase Using LC-MS/MS: Application to Human Gliomas
    Dennis Dietzen, PhD, DABCC, FADLM, Washington University School of Medicine

32104 Emerging Nano-Engineering Technologies for the Management of Chronic Diseases and Cancers
Moderator: Lakshmi Ramanathan, PhD, Memorial Sloan-Kettering Cancer Center
Speakers:

  • Performance Characteristics and Validation in Non-Blood Analysis
    Lakshmi Ramanathan, PhD, Memorial Sloan-Kettering Cancer Center
  • Saliva Based Technologies for the Management of Chronic Disease and Cancer
    Chamindie Punyadeera, PhD, Griffith University
  • Application of Nano-Engineering Technologies in Cancer
    Mijin Kim, PhD, Georgia Institute of Technology

32105 Ethical Decision Making for Laboratory Professionals
Moderator: Ann Gronowski, PhD, DABCC, Washington University School of Medicine
Speakers:

  • Ethical Issues in Laboratory Medicine
    Ann Gronowski, PhD, DABCC, Washington University School of Medicine
  • Ethical Issues Arising From Direct-To-Consumer Genetic Testing
    Valerie Gutman Koch, JD, Health Law and Policy Institute, University of Houston

32106 Is Bad Testing Better Than No Testing?
Moderator: Steven Cotten, PhD, DABCC, NRCC, FADLM, University of North Carolina at Chapel Hill
Speakers:

  • Critical Crossroads: Decision Making in Clinical Testing
    Sarah Hackenmueller, PhD, DABCC, FADLM, Providence Regional Laboratories
  • Decision Dynamics: Testing, Requests, and Patient Care
    Yachana Kataria, PhD, DABCC, Boston University Chobanian and Avedisian School of Medicine

32107 Tools for Recognizing and Eliminating Preanalytical Error
Moderator: Christopher Farnsworth, PhD, DABCC, Washington University in St. Louis
Speakers:

  • Impact of Preanalytical Errors on Patient Care
    Joe El-Khoury, PhD, DABCC, FADLM, Yale University
  • Harnessing the Power of Modern Tools to Reduce Preanalytical Error
    Christopher Farnsworth, PhD, DABCC, Washington University in St. Louis

Session Highlight
32108 Accelerating Point of Need Diagnostics to Meet the Growing Demand for Acute and Advanced Care at Home
Attend this session to explore the current and emerging opportunities to accelerate point-of-need diagnostics to meet the growing demand for acute and advanced care at home.
Moderator: Jared Conley, MD, PhD, MPH, Massachusetts General Hospital
Speakers:

  • Hospital at Home: Current Diagnostic Realities and Emerging Opportunities
    Jared Conley, MD, PhD, MPH, Massachusetts General Hospital
  • Emergency Department at Home: Leveraging Current Technologies to Improve Rapid, Convenient Diagnosis
    David Whitehead, MD, Massachusetts General Hospital

32109 The Nexus of Innovation: How Laboratory Medicine Supports Cellular and Gene Therapy Advancements
Moderator: Zhen Zhao, PhD, DABCC, FADLM, Weill Cornell Medicine
Speakers:

  • Rewards and Challenges of Point-of-Care Cell Manufacturing and Delivery of Novel Gene Modified Cell Therapies
    Amittha Wickrema, PhD, University of Chicago
  • mRNA-Based CAR T Manufacturing and Testing
    Yen-Michael Hsu, MD, PhD, University of Pittsburgh
  • Characterization of a Patient’s Pre-existing Immunity to Viral Vectors in Gene Therapy: Implications and Forward Thinking
    Zhen Zhao, PhD, DABCC, FADLM, Weill Cornell Medicine

Special Q&A with Wallace H. Coulter Lectureship Awardee
62001 Why We Need More Strong Clinical Trials of Laboratory Tests (Meet-the-Expert)

Moderator: David Sacks, MB ChB, FRCPath, National Institutes of Health
Speaker: Patrick Bossuyt, PhD, University of Amsterdam/Amsterdam UMC

12:30 p.m. – 2 p.m.

AMOC Chair Invited Session
32441 Operationalizing Changes to LDT Oversight: Building Roadmaps When the Rubber Hits the Road

Moderator: Mark Marzinke, PhD, DABCC, FADLM, Johns Hopkins University
Speakers:

  • Developing Tools to Manage Decreased Access to LDTs
    Stephen Master, MD, PhD, FADLM, Children's Hospital of Philadelphia
  • LDTs as Medical Devices? Strategies for Prioritization and Regulatory Compliance
    Jonathan Genzen, MD, PhD, ARUP Laboratories
  • Biomarkers and Bureaucracy: Impact of FDA Regulation of Molecular Diagnostics LDTs
    Eric Konnick, MD, University of Washington

32442 Unexpected Results: Using Proficiency Testing to Improve Toxicology and Pharmacogenetic Testing in Your Lab
Moderator: Christine Snozek, PhD, DABCC, FADLM, Mayo Clinic
Speakers:

  • Evolution of Toxicology Proficiency Testing Programs in Response to the Changing Landscape of Drug Testing
    Christine Snozek, PhD, DABCC, FADLM, Mayo Clinic
  • Evolution of PGx Proficiency Testing Programs to Align With Laboratory Practice and Unmet Needs
    Gwendolyn McMillin, PhD, DABCC, University of Utah/ARUP Laboratories
  • Red Herrings and Writeups: Using Analytical Challenges and Expert Resources to Improve and Troubleshoot Performance
    Nicholas Heger, PhD, NRCC, Tufts Medical Center

32443 Moving Beyond Sensitivity and Specificity: Showing the Value of Lab Medicine Through Outcome Measures
Moderator: Zhen Zhao, PhD, DABCC, FADLM, Weill Cornell Medicine
Speakers:

  • Using Outcomes Studies/Measures to Improve the Delivery of Care
    David Grenache, PhD, DABCC, MT (ASCP), Tricore Reference Laboratories
  • The Important Differences Between Observational and Implementation Studies
    Allan Jaffe, MD, Mayo Clinic
  • Beyond the Lab: Transforming Patient Care Through Impactful Testing Outcomes
    Zhen Zhao, PhD, DABCC, FADLM, Weill Cornell Medicine

32444 Implementation of Equations to Estimate Glomerular Filtration Rate at a Pediatric Institution
Moderator: Angela Ferguson, PhD, DABCC, FADLM, Children's Mercy Hospital
Speakers:

  • Reporting Estimate Glomerular Filtration Rate in Pediatrics: A Laboratory Perspective
    Angela Ferguson, PhD, DABCC, FADLM, Children's Mercy Hospital
  • Reporting Estimate Glomerular Filtration Rate in Pediatrics: A Clinician Perspective
    Darcy Weidemann, MD, MHS, Children's Mercy Kansas City

Session Highlight
32445 Pathogen Detection, Machine Learning, or Host Biomarkers: Can Any of These Technologies Help Address the Challenge of Sepsis?
Speakers will highlight recent innovations in sepsis risk stratification tools and molecular detection technologies that have shown potential for rapid, sensitive, and cost-effective diagnosis of septic patients.
Moderator: Nathan Ledeboer, PhD, ABMM, FAAM, Medical College of Wisconsin
Speakers:

  • Transcriptomics, Cell Structure, or Machine Learning: An Overview of the Tools for Detection of Septic Patients
    Nathan Ledeboer, PhD, ABMM, FAAM, Medical College of Wisconsin
  • The Need for Sepsis Biomarkers and Rapid Pathogen Detection: A Perspective From the Emergency Department
    Chadd Kraus, DO, Lehigh Valley Health Network
  • Is Sepsis Detection the Next Troponin and Can the Laboratory Provide the Results at the Time of Need?
    Alison Woodworth, PhD, DABCC, FADLM, CTI Clinical Trials & Consulting

32446 Automating Digital Workflows in the Clinical Laboratory Using Robotic Process Automation
Moderator: Simone Arvisais-Anhalt, MD, University of California, San Francisco
Speakers:

  • Simone Arvisais-Anhalt, MD, University of California, San Francisco
  • Daniel Holmes, MD, St Paul's Hospital Providence Health Care


ADLM-ADA Joint Session
32447 Gestational Diabetes Mellitus: Thinking Beyond Current Testing Guidelines

Moderator: David Sacks, MB ChB, FRCPath, National Institutes of Health
Speakers:

  • Chill Out! Missed Diagnoses of Gestational Diabetes Mellitus Due to Lax Specimen Handling
    Michael Turner, MD, University College Dublin
  • Can We Move Beyond the OGTT for Diagnosis of Gestational Diabetes Mellitus and Postpartum Testing?
    Cuilin Zhang, PhD, Yong Loo Lin School of Medicine/National University of Singapore
  • Is 24 Weeks Too Late? Who Should Be Screened Earlier and What Is the Impact on Outcomes?
    David Simmons, MBBS, MA, Western Sydney University

2:30 p.m. – 4 p.m.

32221 Responding to the Threat of Xylazine and Drug Supply Adulteration: Clinical Testing Strategies and Empowering Point-of-Service Community Drug Checking
Moderator: Adina Badea, PhD, DABCC, Lifespan Health/Rhode Island Hospital/Brown University
Speakers:

  • Best Practices and Testing Strategies in Overdose Patient Management
    Rachel Wightman, MD, FACMT, Alpert Medical School of Brown University
  • Leveraging Clinical Comprehensive Drug Testing in the Age of Drug Supply Adulteration
    Adina Badea, PhD, DABCC, Lifespan Health/Rhode Island Hospital/Brown University
  • Assessing Accuracy and Utility of FTIR Testing and Xylazine Test Strips as Community Drug Checking Tools
    Traci Green, PhD, MSc, Brandeis University/Rhode Island Hospital, Brown University

32222 Emerging Diagnostics to Differentiate Type 1 From Type 2 Myocardial Infarction and Acute Non-Ischemic Myocardial Injury
Moderator: Xander van Wijk, PhD, DABCC, FADLM, Van Wijk Consulting, LLC
Speakers:

  • Distinguishing Type 2 Myocardial Infarction From Myocardial Injury and Type 1 Myocardial Infarction
    Allan Jaffe, MD, Mayo Clinic
  • Serum Biomarkers and Algorithms to Differentiate Myocardial Infarction Types
    Xander van Wijk, PhD, DABCC, FADLM, Van Wijk Consulting, LLC
  • Analysis of Microvesicles for Cardiac Troponin to Detect Reversible Injury and Demand Ischemia
    Alan Wu, PhD, University of California at San Francisco

32223 Navigating Challenges in Tumor Marker Testing: Insights and Solutions
Moderator: Joyce Liao, PhD, DABCC, University of Washington
Speakers:

  • Journey of Body Fluid Tumor Marker Testing: Crossing Sample Variability and Interference
    Jonathan Genzen, MD, PhD, ARUP Laboratories
  • Continuous Transitions: Strategies for Consistent Tumor Marker Testing Across Platforms
    J Shirley Li, PhD, MD, DABCC, NRCC, Ohio State University Wexner Medical Center
  • Beyond Intended Use: Designing Validation Protocols for Accurate Tumor Marker Testing in Diverse Patient Populations
    Qian Sun, PhD, DABCC, Corewell Health

32224 International Quality Indicators: Experiences, Opportunities, and Challenges
Moderator: Fernando Berlitz, MBA, Controllab
Speakers:

  • Benchmarking of Laboratory Processes: IFCC WG-LEPS Guidelines and the Canadian Experience
    Vincent De Guire, PhD, MSc, Maisonneuve-Rosemont Hospital
  • Benchmarking of Laboratory Processes: The Brazilian Indicators Program
    Fernando Berlitz, MBA, Controllab

Session Highlight
32225 Operationalizing AI in Lab Medicine: Approaches for Effective Machine Learning Integration and Deployment

Clinical laboratories are leading the technological evolution of machine learning in healthcare but may lack practical guidance. This session will bridge that gap and provide strategies.
Moderator: Stephen Master, MD, PhD, FADLM, Children's Hospital of Philadelphia
Speakers:

  • Beyond the Buzz: Practical Pathways to AI Deployment in Clinical Laboratories
    Thomas Durant, MD, Yale University
  • Are You Prepared? Appraisal and Evaluation of AI Applications for Laboratory Medicine
    David McClintock, MD, Mayo Clinic
  • From Theory to Practice: Lessons Learned in Implementation of a Machine Learning Solution for Preanalytical Error Detection
    Nicholas Spies, MD, Washington University in St. Louis

32226 Improving Lead Testing Access: Leaning Into Decision Support Tools and Lead Screening by Dried-Blood Spots
Moderator: Jessica Colon-Franco, PhD, DABCC, FADLM, Cleveland Clinic
Speakers:

  • Leveraging Informatics to Identify Children at Risk of Lead Toxicity and Increase Screening Rates
    Roopa Thakur, MD, Cleveland Clinic
  • The Role of the Clinical Laboratory in Local Lead Testing Surveillance Programs: A Pilot Study Using Dried Blood Spots
    Jessica Colon-Franco, PhD, DABCC, FADLM, Cleveland Clinic

32227 Practical Update on Laboratory Testing for Bleeding Problems: Adapting to New Evidence, Guidelines and Therapies, With Illustrative Cases
Moderator: Morayma Reyes-Gil, MD, PhD, Cleveland Clinic
Speakers:

  • Update on von Willebrand Disease Testing
    Catherine Hayward, MD, PhD, FRCP, McMaster University
  • Platelet Disorders: Diagnostic Testing
    Geoffrey Wool, MD, PhD, University of Chicago
  • Factor Deficiencies: Diagnostic and Treatment Monitoring Testing
    Morayma Reyes-Gil, MD, PhD, Cleveland Clinic

32228 The Gift of Life: The Remarkable Role the Clinical Laboratory Plays in Organ Donation
Moderator: Amber Carriker, BS, C(ASCP), Mid America Transplant
Speakers:

  • The Unique Requirements for Organ and Tissue Donor Screening Assays
    Amber Carriker, BS, C(ASCP), Mid America Transplant
  • Compatibility Testing: I’ll Accept That (Human and Xeno)!
    Sam Ho, PhD, ABHI, Gift of Hope Organ & Tissue Donor Network
  • Managing Brain Dead Donors in a Non-Traditional Setting
    Selena Warden, MSc, ASCP, Southwest Transplant Alliance

32229 Advances and Limitations of Consumer-Initiated Laboratory Testing
Moderator: Julie Shaw, PhD, The Ottawa Hospital University of Ottawa/Eastern Ontario Regional Laboratories Association
Speakers:

  • How Is This Lab Different From Yours? The Ins and Outs of a Laboratory Where Consumer-Initiated Testing Is the Norm
    Dina Greene, PhD, DABCC, University of Washington. 
  • Your Results Are Back! Clinical Support for Consumer-Initiated Testing
    Avantika Waring, MD, 9amHealth
  • Ethical Considerations for Consumer-Initiated Testing
    Melissa Budelier, PhD, DABCC, TriCore Reference Laboratories

Back to top

 

Tuesday, July 30

10:30 a.m. –12 p.m.

33101 ADLM Healthcare Forum: The Impact of LDT Oversight on the Delivery of Care
Moderator: Joe Wiencek, PhD, DABCC, NRCC, FADLM, Vanderbilt University Medical Center
Speakers:

  • The Necessity of LDTs in Pediatric Care: Lack of Access Leads to Compromised Patient Care
    Patricia Jones, PhD, DABCC, FADLM, University of Texas Southwestern Medical Center
  • LDT Oversight by the Experts: Finding Alternatives to the Proposed FDA Rule
    Dennis Dietzen, PhD, DABCC, FADLM, Washington University School of Medicine

33102 Clinical Laboratory Accreditation Agencies: What You Should Know Before, During, and After an Inspection
Moderator: Veronica Luzzi, PhD, DABCC, TriCore Reference Laboratories
Speakers:

  • CLIA, COLA, TJC: What You Should Know but Are Afraid to Ask
    Veronica Luzzi, PhD, DABCC, TriCore Reference Laboratories
  • Navigating Through Intentions of Regulatory Checklists
    Jude Abadie, PhD, DABCC, DABMG, FADLM, FACMG, Texas Tech University Health Sciences Center
  • Enhancing Laboratory Quality with ISO15189
    Alejandro Molinelli, PhD, NRCC, St. Jude Children's Research Hospital

ADLM-Endocrine Society Joint Session
33103 Clinical Assay Issues: What Endocrinologists Will Ask You

Moderator: David Sacks, MB ChB, FRCPath, National Institutes of Health
Speakers:

  • Eucalcemic Hyperparathyroidism: Is it Primary Hyperparathyroidism?
    Joseph Shaker, MD, Medical College of Wisconsin
  • How to Accurately Diagnose Growth Hormone Abnormalities?
    Jeannette Goguen, MD, St Michael's Hospital
  • Antibodies Guiding the Diagnosis of Hyperglycemia and Hypoglycemia
    Adrian Vella, MD, Mayo Clinic

33104 Clinical Chemistry Journal Hot Topics: A Point-Counterpoint on LDL-C Equations
Moderator: Jason Park, MD, PhD, DABCC, Children's Medical Center
Speakers:

  • The Clinical Importance of LDL-C
    Ian Young, MD, Queen's University Belfast
  • Calculation of LDL-C Using the Martin-Hopkins Equation
    Seth Martin, MD, MHS, Johns Hopkins University School of Medicine
  • Calculation of LDL-C Using the Sampson-NIH Equation
    Alan Remaley, MD, NIH

Special Interactive Session
33105 Improv and the Art of Medicine: Adaptable Skills for an Uncertain World
 Life is unpredictable. Improvisation is a skill that can be used to respond to difficult unexpected challenges and conversations. Join this interaction session to learn how.
Speaker: Belinda Fu, MD, Mayutica Institute / TheImprovDoc

33106 Dipping Your Toes Into the Data Analytics Pool: A Session With Laboratory Professionals Working on Informatics Projects
Moderator: Mark Cervinski, PhD, DABCC, FADLM, Dartmouth-Hitchcock Medical Center
Speakers:

  • Through the Shallows: Regional Quality Control and Calibrations
    Dustin Bunch, PhD, DABCC, Nationwide Children's Hospital
  • Developing Machine Learning Models to Improve Test Utilization and Laboratory Stewardship
    He Yang, PhD, DABCC, Weill Cornell Medicine
  • From Idea to Beta Testing: Use cases to build your Analytics Skills
    Steven Cotten, PhD, DABCC, NRCC, FADLM, University of North Carolina at Chapel Hill

33107 Capital Purchases and Cost Accounting for Lab Leaders: Essential Skills for Demonstrating the Value of the Laboratory
Moderator: David Shiembob, BS, MBA, C (ASCP), ARUP Laboratories
Speakers:

  • Making the Case for Capital Purchases: Translating Ideas Into Action
    David Shiembob, BS, MBA, C (ASCP), ARUP Laboratories
  • The Cost of Doing Business: Demystifying Lab Cost Analysis
    Zachary Zaret, MHA, DLM(ASCP)CM, ARUP Laboratories

33108 Informatics and Technological Approaches for Addressing the Challenges of Large-Scale Genomic Testing
Moderator: Kai Lee Yap, PhD, DABMGG, Ann & Robert H Lurie Children's Hospital of Chicago
Speakers:

  • Validation of Natural Language Processing (NLP) Algorithms for Deep Phenotyping of Patients Receiving Genomic Testing
    Kai Lee Yap, PhD, DABMGG, Ann & Robert H Lurie Children's Hospital of Chicago
  • Overcoming the Challenges of Whole Exome Sequencing for the Diagnosis of Patients With Monogenic Kidney Disease
    Daniela del Gaudio, PhD, ABMGG, University of Chicago
  • Long-Read Whole Genome Sequencing for Solving Undiagnosed Rare Diseases
    Danny Miller, MD, PhD, ABMGG, University of Washington

33109 ADLM Academy Distinguished Abstracts: Innovative Applications for Today and Emerging Discoveries for Tomorrow
Moderator: Gyorgy Abel, MD. PhD, DABCC, FADLM, Lahey Hospital & Medical Center, Beth Israel Lahey Health
Speakers: ADLM Academy Distinguished Abstract award-winners to be determined 

2:30 p.m. – 4 p.m.

33221 Speaking Their Language: Communicating to Hospital Leadership the Essential Role of the Laboratory in Value-Based Care
Moderator: James Crawford, MD, PhD, Northwell Health
Speakers:

  • Working With Hospital and Health System Leadership: The Northwell Health Laboratories Story
    Dwayne Breining, MD, Northwell Health
  • Importance of the Hospital and Health System Laboratory From an Administrators Perspective
    Alex Hellinger, DPT, MBA, FACHE, Northwell Health

33222 Course Correction: A Chemistry Compliance Compilation
Moderator: Grace Williams, PhD, DABCC, Virginia Commonwealth University
Speakers:

  • Resolving Laboratory Errors
    Jacqueline Hubbard, PhD, C(ASCP), DABCC, NRCC, Three Rivers Diagnostics
  • Resolving Noncompliant Laboratory Procedures
    Grace Williams, PhD, DABCC, Virginia Commonwealth University

33223 Unexpected Toxicology Results as Real-Time Opportunities for Collaboration
Moderator: Nicholas Heger, PhD, NRCC, Tufts Medical Center
Speakers:

  • Unexpected Negatives
    Nicholas Heger, PhD, NRCC, Tufts Medical Center
  • Unexpected Positives
    Danyel Tacker, PhD, DABCC, FADLM, West Virginia University
  • Practical Considerations for LC-MS-Based Toxicology Analysis
    Steven Conklin-Lopez, BS, PhD, NRCC, Labcorp

Session Highlight
33224 Acute Kidney Injury Biomarkers: Ready for Primetime?

Learn the latest on the shifting paradigm in AKI biomarkers through case-based discussion to see how limits of "one size fits all" and advances in new diagnostic criteria impact outcomes.
Moderator: Robert Nerenz, PhD, DABCC, Medical College of Wisconsin
Speakers:

  • Moving Beyond Creatinine: A New Era in Acute Kidney Injury Diagnosis
    Robert Nerenz, PhD, DABCC, Medical College of Wisconsin
  • CXCL9 for Diagnosis of Acute Interstitial Nephritis
    Dennis Moledina, MD, PhD, FASN, Yale School of Medicine
  • NGAL for Acute Kidney Injury Diagnosis in Cirrhotic Patients
    Kevin Regner, MD, MS, FASN, Medical College of Wisconsin

33225 Care Continuum: How Hematologists, Laboratorians, and Transfusion Medicine Physicians Partner to Diagnose, Manage, and Support Patients with Sickle Cell Disease
Moderator: Zahra Shajani-Yi, PhD, DABCC, NRCC, FADLM, Labcorp
Speakers:

  • The Hematologist’s View: Clinical and Hematological Effects of Sickle Cell Disease
    Susanna Curtis, MD, PhD, Icahn School of Medicine at Mt Sinai,
  • The Laboratory View: Laboratory Methods Used to Diagnose and Manage Sickle Cell Disease
    Sean Campbell, PhD, DABCC, FADLM, Montefiore Medical Center
  • The Transfusion Medicine Physician's View: Transfusion and Apheresis in Sickle Cell Disease Care
    Caroline Alquist, MD, PhD, F(ACHI), FCAP, University of Cincinnati

33226 Getting Started with Data Analytics: Indirect Reference Intervals as a Case Study
Moderator: Sarah Wheeler, PhD, FADLM, University of Pittsburgh Medical Center
Speakers:

  • Accessing and Analyzing Laboratory Data: Tools, Techniques, and Tips
    Sarah Wheeler, PhD, FADLM, University of Pittsburgh Medical Center
  • Exploring Data Analytics Through Case Studies in Indirect Reference Interval Applications
    Kelly Doyle, PhD, DABCC, FADLM, ARUP Laboratories
  • Systematic Ways to Avoid Fantasy and Self-Deception With Indirect Reference Interval Determination
    Daniel Holmes, MD, St Paul's Hospital Providence Health Care

33227 Metabolic Emergencies in the Pediatric Patient: Laboratory Differentiation of Inborn Errors of Metabolism and Acute Drug Exposure
Moderator: Kara Lynch, PhD, DABCC, FADLM, University of California, San Francisco
Speakers:

  • Diagnostic Evaluation of Pediatric Patients with Acute Metabolic Derangements
    Kara Lynch, PhD, DABCC, FADLM, University of California, San Francisco
  • Laboratory Game of Clue: Metabolic Disorder or Exogenous Exposure?
    Sydney Strickland, PhD, DABCC, Labcorp

33228 Microbes Meet Machines: Total Laboratory Automation in Clinical Microbiology
Moderator: Vincent Streva, PhD, Northwell Health Laboratories
Speakers:

  • Digital Bacteriology: Lessons Learned From Implementing the Copan WASPLab Full Lab Automation System
    Caitlin Otto, PhD, New York University Tisch Hospital
  • Adventures in Automation: Navigating Challenges and Successes with the BD Kiestra Total Lab Automation System
    Jamie Lemon, PhD, Northwell Health Laboratories

33229 Navigating Constitutional Genomic Disorders Throughout the Exome
Moderator: Jude Abadie, PhD, DABCC, DABMG, FADLM, FACMG, Texas Tech University Health Sciences Center
Speakers:

  • Building Exome Testing Infrastructure to Explore Clinical Genetic Cases
    Joel Lefferts, PhD, DABCC, ABB, Dartmouth-Hitchcock Medical Center
  • Interpretation of Exome Sequencing to End the Diagnostic Odyssey
    Jude Abadie, PhD, DABCC, DABMG, FADLM, FACMG, Texas Tech University Health Sciences Center

Back to top

 

Wednesday, July 31

10:30 a.m. – 12 p.m.

34101 International Regulatory Considerations for Laboratory-Developed Tests: Opportunities and Risks for Patient Care
Moderator: Christina Lockwood, PhD, ABMG, DABCC, University of Washington
Speakers:

  • Impact of Diagnostic Regulations on Laboratory-Developed Tests in the United States
    Christina Lockwood, PhD, ABMG, DABCC, University of Washington
  • Regulatory Considerations for Laboratory-Developed Tests From the European Perspective
    Speaker to be Determined 
  • Off-Label Diagnostics: An Analogy to Individualized Therapeutic Medicine: The Oncology Case
    Speaker to be Determined

Session Highlight
34102 Ensuring Equity and Fairness in Machine Learning and Data Analytics
Machine learning and data analytics promise to improve the value and efficiency of laboratory testing. However, there are threats of these tools generating unfair predictions and perpetuate disparities. Learn how this can happen and how to avoid.
Moderator: Mark Zaydman, MD, PhD, Washington University in St. Louis
Speakers:

  • Conceptualizing and Measuring Algorithmic Fairness
    Mark Zaydman, MD, PhD, Washington University in St. Louis
  • How Machine Learning Algorithms Incorporate Biases and Make Unfair Predictions
    Weishen Pan, PhD, Weill Cornell Medicine
  • Strategies and Tools for Engineering Algorithmic Fairness
    Jenny Yang, MSc, BASC, University of Oxford

34103 Changing the Sexually Transmitted Infection Control Paradigm: Novel Diagnostic and Treatment Strategies
Moderator: Barbara Van Der Pol, PhD, MPH, University of Alabama at Birmingham
Speakers:

  • Changing Access to Sexually Transmitted Infection Diagnostics: Improving Reach With New Technologies and Applications
    Barbara Van Der Pol, PhD, MPH, University of Alabama at Birmingham
  • Diagnostics and Enhanced Laboratory Approaches to Combat Neisseria Gonorrhoeae Antimicrobial Resistance
    Olusegun Soge, PhD, MSc, University of Washington
  • Anticipating and Monitoring Antibiotic Resistance in the Era of Doxycycline PEP
    Aniruddha Hazra, MD, University of Chicago Medicine

34104 Clinical Laboratory Investigation of Lipid Disorders: A Practical Approach
Moderator: Tahir Pillay, MD, PhD, University of Pretoria
Speakers:

  • Laboratory Tests for Lipid Disorders: Navigating the Panels
    Tahir Pillay, MD, PhD, University of Pretoria
  • Practical Case Studies of Common Dyslipidemias
    Patrick Twomey, MD, Chemical Pathology, St Vincent's University Hospital
  • Alignment of Laboratory Testing With Management and Treatment Guidelines for Dyslipidemias
    Amy Saenger, PhD, DABCC, FADLM, Hennepin County Medical Center

34105 Clinical Toxicology in the Courtroom: How to Serve as an Expert Witness
Moderator: Saeed Jortani, PhD, DABCC, FADLM, University of Louisville
Speakers:

  • Presiding Judge
    Eric Haner, JD, Kentucky Administrative Office of the Courts
  • Defense and Plaintiff Attorneys
    Bo Bolus, JD, Bolus Law Office
    Matthew Gay, JD, Boehl Stopher and Graves, LLP
  • Expert Witnesses
    Alan Wu, PhD, University of California at San Francisco
    Saeed Jortani, PhD, DABCC, FADLM, University of Louisville

34106 The Changing Landscape for Cystic Fibrosis Testing and Treatment
Moderator: Lisa Johnson, PhD, DABCC, Seattle Children's Hospital
Speakers:

  • Diagnostic Guidelines and Challenges for Cystic Fibrosis
    Heather Nelson, PhD, DABCC, ARUP Laboratories
  • The Impact of Novel Therapies on the Laboratory Testing Results: A Collaborative Study With a Cystic Fibrosis Care Center
    Tatiana Yuzyuk, PhD, ABMG, ARUP Laboratories
  • Inequalities in Cystic Fibrosis Outcomes and Care
    Catherine McDonald, PhD, RDN, Primary Children’s Hospital

34107 JALM Hot Topics: Current Challenges and Future Promise in Molecular Diagnostics
Moderator: Nikoletta Sidiropoulos, MD, University of Vermont Medical Center
Speakers:

  • Optimizing Molecular Diagnostics: Stewardship for Precision Testing, Minimizing Costs, and Enhancing Clinical Relevance in Infectious Disease Management
    Erin Graf, PhD, D(ABMM), Mayo Clinic Arizona
  • Genomic Data Optimization: Cost-Effective Utilization and Future Opportunities in Germline Sequencing for Enhanced Patient Care and Diagnostic Resolution
    Ann Moyer, MD, PhD, Mayo Clinic
  • Genomic Testing Equity: Ensuring Fair and Inclusive Access for All in the Pursuit of Personalized Healthcare Advancements
    Nikoletta Sidiropoulos, MD, University of Vermont Medical Center

34108 Point-of-Care Testing Challenges in Traditional and Non-Traditional Settings
Moderator: Heather Stieglitz, PhD, DABCC, Ohio State University Medical Center
Speakers:

  • Documenting Critical Results Without the Laboratory Information System
    Heather Stieglitz, PhD, DABCC, Ohio State University Medical Center
  • Influencing Without Authority: Strengthening Point-of-Care Testing Oversight Across a Healthcare System
    Nichole Korpi-Steiner, PhD, DABCC, University of North Carolina, Chapel Hill
  • Point-of-Care Testing in Unusual Healthcare Settings
    Sarah Wheeler, PhD, FADLM, University of Pittsburgh Medical Center

2:30 p.m. – 4 p.m.

34221 Alzheimer’s Disease and the New Therapeutic Age
Moderator: Leslie Shaw, PhD, DABCC, Hospital of the University of Pennsylvania
Speakers:

  • Progress on Therapeutics for Alzheimer’s Disease
    Philip Lee, MD, FRCPC, St. Paul's Hospital
  • Biomarkers in Alzheimer’s Disease: Learnings from Clinical Trials
    Leslie Shaw, PhD, DABCC, Hospital of the University of Pennsylvania
  • Genetic and Other Biomarkers for Alzheimer's Disease: Patient and Family Counseling Considerations
    Emily Dwosh, BEd, MSc, UBC Hospital

34222 Best Practices and Innovations in Clinical and Technical Consultation by Medical Laboratory Professionals
Moderator: Nadia Ayala-Lopez, MLS, PhD, DABCC, MT (ASCP), NRCC, Labcorp
Speakers:

  • Interpretive Comments, Clinical Decision Support, and Patient-Specific Consults to Improve Health Care Delivery
    Alejandro Molinelli, PhD, NRCC, St. Jude Children's Research Hospital
  • Best Practices for Actionable and Valuable Medical Laboratory Consultations
    Nadia Ayala-Lopez, MLS, PhD, DABCC, MT (ASCP), NRCC, Labcorp

Session Highlight
34223 New Diagnostic Laboratory Assessments in Polycystic Ovary Syndrome

New tests are available and emerging for the diagnosis of PCOS. Also, new genome-wide association studies have expanded the polygenic risk score (PRS) for PCOS along with new criteria. Join this session to get up to date on biomarkers, diagnostics, and new criteria in PCOS.
Moderator: Corrine Welt, MD, University of Utah School of Medicine
Speakers:

  • Antimullerian Hormone as a Replacement for Ultrasound in the Diagnosis of Polycystic Ovary Syndrome
    Erica Johnstone, MD, MHS, University of Utah
  • The Polygenic Risk Score for Polycystic Ovary Syndrome: Implications for Comorbidities
    Corrine Welt, MD, University of Utah School of Medicine
  • 11-Oxygenated Androgens in the Diagnosis of Polycystic Ovary Syndrome and Congenital Adrenal Hyperplasia
    Richard Auchus, MD, PhD, University of Michigan

34224 Confronting a New Wave of Opioid Overdoses Through Surveillance Testing: Public Health Initiatives, Wastewater Epidemiology, and Comprehensive Drug Checking Analysis
Moderator: Adina Badea, PhD, DABCC, Lifespan Health/Rhode Island Hospital/Brown University
Speakers:

  • Wastewater-Based Epidemiology for Population Level Substance Use Surveillance
    Peter Chai, MD, MMS, Brigham and Women’s Hospital
  • Insights From Biosurveillance: A Laboratory-Based Approach for Combating Rhode Island’s Opioid Epidemic
    Louis Marchetti, PhD, NRCC(TC), Rhode Island State Health Laboratories
  • High Resolution Mass Spectrometry Comprehensive Drug Testing to Characterize Local Drug Supply
    Adina Badea, PhD, DABCC, Lifespan Health/Rhode Island Hospital/Brown University

34225 Adventures in Clinical Decision Support: Interactive Cases in Laboratory Stewardship
Moderator: Ronald Jackups, MD, PhD, Washington University in St. Louis
Speakers:

  • Antibody Autopilot: CDS Solutions for Paraneoplastic Autoantibody Evaluations
    Robert Nerenz, PhD, DABCC, Medical College of Wisconsin
  • Order Incontinence: CDS Solutions for Clostridium Difficile Testing
    Ronald Jackups, MD, PhD, Washington University in St. Louis
  • Stop the Bleeding: CDS Solutions for Peripheral Smear Review Requests
    Joseph Rudolf, MD, University of Utah School of Medicine

34226 Academy Conversations Between Clinical Laboratorians and Clinicians: Ideal Laboratory Report of Cervical Cancer Detection and Calculation of CIN3+ Risk
Moderator: Yusheng Zhu, PhD, DABCC, Pennsylvania State University Hershey Medical Center
Speakers:

  • Ideal Laboratory Report for Cervical Cancer Detection and Calculation of Cervical Precancer or Cancer (CIN3+) Risk
    Yusheng Zhu, PhD, DABCC, Pennsylvania State University Hershey Medical Center
  • Interpretation of Risk of Cervical Precancer or Cancer (CIN3+) and Individualized Patient Management Based on Risks
    Annie Leung, MD, McGill University Health Centre

34227 The Anatomy of the Grey Zone: Ambiguous Immunofixation/Immunotyping Results and How to Objectively Approach Interpretation
Moderator: Robert Maynard, PhD, NRCC, University of Kentucky
Speakers:

  • Three’s Company: Electrophoresis (Gel and Capillary) and Mass Spectrometry for the Detection and Isotyping of Monoclonal Proteins
    Ria Fyffe-Freil, PhD, University of Nebraska Medical Center
  • So, You’re New Here? A Case-Based Approach to the Initial Detection of Monoclonal Gammopathies and Equivocal Isotyping Results
    Robert Maynard, PhD, NRCC, University of Kentucky
  • In It for the Long Haul: Your Toolbox for Accurately Detecting Remission and Relapse While Monitoring Patients With Monoclonal Gammopathies
    Shelby Hutcherson, PhD, DABCC, Memorial Sloan Kettering Cancer Center

34228 Current and Future State of Metagenomics for Infectious Diseases Testing
Moderator: David Gaston, MD PhD, Vanderbilt University Medical Center
Speakers:

  • Leveraging Clinical Impact With Metagenomic Testing
    Esther Babady, PhD, D(ABMM), FIDSA, Memorial Sloan Kettering Cancer Center
  • Roadmap for the Future: Evidence Generation and Optimizing Diagnostic Integration
    David Gaston, MD PhD, Vanderbilt University Medical Center"

Back to top

 

Thursday, August 1

10:30 a.m. - 12 p.m.

Session Highlight
35101 Effective Communication with C-Suite Executives: A Chief of Operations and a Department Chair Perspective

Experts share practical administrative and leadership insights for developing collaborations among laboratory medicine professionals and C-suite executives on topics that include budget, business plan development, relative value units (RVUs), staffing, and more.
Moderator: Victoria Zhang, PhD, MBA, DABCC, FADLM, University of Rochester Medical Center
Speakers:

  • Overview of Healthcare Leadership Structure and C-Suite Functions
    Victoria Zhang, PhD, MBA, DABCC, FADLM, University of Rochester Medical Center
  • Effective Communication With Hospital C-Suite Executives: A Chief of Operations Perspective
    Kathy Parrinello, PhD, RN, University of Rochester Medical Center
  • Effective Communication With Hospital C-Suite Executives: A Department Chair Perspective
    Bruce Smoller, MD, University of Rochester Medical Center

35102 Preeclampsia in the Unites States: Clinical Details, Best Practices in Laboratory Medicine, and Impact of Foundational Support
Moderator: Sydney Strickland, PhD, DABCC, Labcorp
Speakers:

  • Clinical Features and Presentation of Preeclampsia
    Emily Rosenfeld, DO, Rutgers Robert Wood Johnson Medical School
  • Laboratory Testing to Screen Women for Development of Preeclampsia and Progression to Severe Features
    Sydney Strickland, PhD, DABCC, Labcorp
  • Current State of Preeclampsia Within the US
    Laney Poye, MIA, Preeclampsia Foundation

35103 Primer on Regulatory Aspects of In Vitro Diagnostics: How to Make Sense of the Alphabet Soup
Moderator: William Clarke, PhD, MBA, DABCC, FADLM, Johns Hopkins University School of Medicine
Speakers:

  • Premarket Approvals and 510(k)s: How Commercial Diagnostics Work Their Way Through the US FDA Process
    Salvatore Salamone, PhD, Saladax Biomedical Inc
  • CPTs, PLAs, and the CLFS: How Clinical Test Reimbursement is Determined
    William Clarke, PhD, MBA, DABCC, FADLM, Johns Hopkins University School of Medicine
  • LDTs, CLIA, and the FDA: The Regulatory Landscape and the Implications of Change
    Stephen Master, MD, PhD, FADLM, Children's Hospital of Philadelphia

35104 The Toxicological Problem Accumulating Inside of Us All: Breaking Down the Uses, Abuses, and Growing Public Health Concerns over PFAS
Moderator: Frederick Strathmann, PhD, MBA, DABCC, MOBILion
Speakers:

  • The Use of High Resolution Mass Spectrometry for the Discovery of Novel PFAS
    Mark Strynar, PhD, US Environmental Protection Agency
  • PFAS Human Exposure, Health Impacts, Consumer Product Testing, and Risk Communication
    Jenna Hua, PhD, Million Marker
  • PFAS Pharmacokinetics and Laboratory Monitoring
    Laura Labay, PhD, ABFT, DABCC, NMS Labs

35105 The Use of Intelligent Algorithms and AI in Pathology: Applications and Apprehensions
Moderator: Lauren Starbrook, MSc, DClinSci, New Cross Hospital
Speakers:

  • Intelligent Algorithms in Biochemistry: Improving the Diagnosis of Familial Hypercholesterolaemia
    Lauren Starbrook, MSc, DClinSci, New Cross Hospital
  • Leveraging Machine Learning to Improve Detection of Analyzer Errors in a Busy Automated Laboratory
    Tejas Kalaria, MD, MRCP, FRCPath, Black Country Pathology Services
  • Is ChatGPT Capable of Producing Court-Ready Reports in Post-Mortem Cases?
    Kate Rice-Davies, University Hospitals Leicester NHS Trust

35106 A Pathway Towards Greater Sustainability in Lab Medicine
Moderator: Joe Wiencek, PhD, DABCC, NRCC, FADLM, Vanderbilt University Medical Center
Speakers:

  • Advancing Sustainability Practices in Clinical Chemistry
    Joe Wiencek, PhD, DABCC, NRCC, FADLM, Vanderbilt University Medical Center
  • Tools for Building a Global Culture of Sustainability in Science
    James Connelly, My Green Lab
  • Exploring the Paradox of Harming Health by Delivering Health Care
    Ilyssa Gordon, MD, PhD, Cleveland Clinic

Back to top